MapLight Therapeutics (MPLT) insider trading in the last 6 months
2 insiders bought $65.5M, 6 sold $7.8M.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Form 4 filings, newest first
Who files at MapLight Therapeutics
Cluster buys at MPLT
2 insiders bought MPLT in the last 6 months: Catalyst4, Inc. and Troy Cox.
Questions about MPLT's insider trades
Are MPLT insiders buying or selling?
2 insiders bought $65.5M across 6 filings, and 6 insiders sold $7.8M across 27 filings, in the last 6 months. The newest filing: Christopher A. Kroeger, Chief Executive Officer, sold $595K on Oct 15, 2026. 2 insiders bought MPLT in the last 6 months: Catalyst4, Inc. and Troy Cox.
Who are MPLT's biggest insider sellers?
By the dollars of their sales in the last 6 months: Christopher A. Kroeger (Chief Executive Officer), 8 sales; James Woodruff Lillie (Chief Scientific Officer), 8 sales; Kristopher Hanson (General Counsel), 8 sales. 6 insiders sold in all.
When did an MPLT insider last buy?
Catalyst4, Inc., 10% owner, bought MPLT shares on Aug 14, 2026, filed Aug 18, 2026, the newest insider buy on record.
MapLight Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.